Modulation of apoptotic regulatory proteins and early activation of cytochrome C following systemic 3-nitropropionic acid administration

被引:22
作者
Antonawich, FJ
Fiore-Marasa, SM
Parker, CP
机构
[1] SUNY Stony Brook, Dept Neurol, Stony Brook, NY 11794 USA
[2] SUNY Stony Brook, Dept Neurobiol, Stony Brook, NY 11794 USA
[3] Northport DVA Med Ctr, Northport, NY USA
关键词
striatum; 3-NP; Huntington's disease; apoptosis; mitochondria;
D O I
10.1016/S0361-9230(01)00761-4
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The present study utilized the administration of the mitochondrial toxin, 3-nitropropionic acid (3-NP), to mimic the pathology associated with Huntington's disease (HD). 3-NP causes striatal cell degeneration via the inhibition of succinate dehydrogenase. There is growing evidence suggesting the role of apoptosis in 3-NP cell death. TUNEL staining, DNA fragmentation, and changes in bcl-2 mRNA levels have been associated with this metabolic impairment. We wish to further elucidate the apoptotic cascade in this model of HD pathogenesis. 3-NP was administered to rats intraperitoneally at 20 mg/kg/day for up to 3 days. At 3 days, characteristic behavioral and morphological effects became evident. While cell death did not become apparent within the first 3 days, there were changes in the levels of apoptotic regulatory proteins and translocation of cytochrome c. Within 24 In after 3-NP administration there were elevations in both bcl-xl and bax. However, bcl-xl protein levels quickly returned to control levels while bax levels continued to increase, resulting in a detrimental bax/bcl-xl ratio. Bax has been demonstrated to facilitate cytochrome c release by forming mitochondrial pores. We saw cytochrome c translocate from the mitochondria to the cytosol approximately 24 In after initial 3-NP administration when compared to saline-injected controls. This evidence generated using the 3-NP degeneration model may help elucidate the apoptotic cascade associated with HD neurodegeneration. (C) 2002 Elsevier Science Inc.
引用
收藏
页码:647 / 649
页数:3
相关论文
共 19 条
[1]   Metabolic compromise with systemic 3-nitropropionic acid produces striatal apoptosis in Sprague-Dawley rats but not in BALB/c ByJ mice [J].
Alexi, T ;
Hughes, PE ;
Knüsel, B ;
Tobin, AJ .
EXPERIMENTAL NEUROLOGY, 1998, 153 (01) :74-93
[2]   Translocation of cytochrome c following transient global ischemia in the gerbil [J].
Antonawich, FJ .
NEUROSCIENCE LETTERS, 1999, 274 (02) :123-126
[3]   BCL-2 transduction, using a herpes simplex virus amplicon, protects hippocampal neurons from transient global ischemia [J].
Antonawich, FJ ;
Federoff, HJ ;
Davis, JN .
EXPERIMENTAL NEUROLOGY, 1999, 156 (01) :130-137
[4]   Bcl-x1 bax interaction after transient global ischemia [J].
Antonawich, FJ ;
Krajewski, S ;
Reed, JC ;
Davis, JN .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1998, 18 (08) :882-886
[5]   Oxidative stress is attenuated in mice overexpressing BCL-2 [J].
Bogdanov, MB ;
Ferrante, RJ ;
Mueller, G ;
Ramos, LE ;
Martinou, JC ;
Beal, MF .
NEUROSCIENCE LETTERS, 1999, 262 (01) :33-36
[6]   Systemic, but not intraparenchymal, administration of 3-nitropropionic acid mimics the neuropathology of Huntington's disease: A speculative explanation [J].
Borlongan, CV ;
Nishino, H ;
Sanberg, PR .
NEUROSCIENCE RESEARCH, 1997, 28 (03) :185-189
[7]   OXIDATIVE-PHOSPHORYLATION AND PHOTOPHOSPHORYLATION [J].
BOYER, PD ;
CHANCE, B ;
ERNSTER, L ;
MITCHELL, P ;
RACKER, E ;
SLATER, EC .
ANNUAL REVIEW OF BIOCHEMISTRY, 1977, 46 :955-1026
[8]   Excitotoxicity is required for induction of oxidative stress and apoptosis in mouse striatum by the mitochondrial toxin, 3-nitropropionic acid [J].
Kim, GW ;
Copin, JC ;
Kawase, M ;
Chen, SF ;
Sato, S ;
Gobbel, GT ;
Chan, PH .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2000, 20 (01) :119-129
[9]  
KRAJEWSKI S, 1995, J NEUROSCI, V15, P6364
[10]   Cell-specific induction of apoptosis by microinjection of cytochrome c - Bcl-x(L) has activity independent of cytochrome c release [J].
Li, F ;
Srinivasan, A ;
Wang, Y ;
Armstrong, RC ;
Tomaselli, KJ ;
Fritz, LC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (48) :30299-30305